首页> 美国卫生研究院文献>International Scholarly Research Notices >Natural Remedies for the Treatment of Beta-Thalassemia and Sickle Cell Anemia—Current Status and Perspectives in Fetal Hemoglobin Reactivation
【2h】

Natural Remedies for the Treatment of Beta-Thalassemia and Sickle Cell Anemia—Current Status and Perspectives in Fetal Hemoglobin Reactivation

机译:治疗β-地中海贫血和镰状细胞性贫血的自然疗法—胎儿血红蛋白活化的现状和前景

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

For the treatment of β-thalassemia and sickle cell disease (SCD), pharmacological induction of fetal hemoglobin (HbF) production may be a promising approach. To date, numerous studies have been done on identifying the novel HbF-inducing agents and understanding the underlying mechanism for stimulating the HbF production. In this review, we have summarized the identified HbF-inducing agents by far. By examining the action mechanisms of the HbF-inducing agents, various studies have suggested that despite the ability of stimulating HbF production, the chemotherapeutic agents could not be practically applied for treating β-hemoglobinopathies, especially β-thalassemia, due to the their cytotoxicity and growth-inhibitory effect. Owing to this therapeutic obstacle, much effort has been put on identifying new HbF-inducing agents from the natural world with the combination of efficacy, safety, and ease of use. Therefore, this review aims to (i) reveal the novel screening platforms for identifying potential inducers with high efficiency and accuracy and to (ii) summarize the new identified natural remedies for stimulating HbF production. Hopefully, this review can provide a new insight into the current status and future perspectives in fetal hemoglobin reactivation for treating β-thalassaemia and SCD.
机译:对于β地中海贫血和镰状细胞病(SCD)的治疗,胎儿血红蛋白(HbF)产生的药理诱导可能是一种有前途的方法。迄今为止,已经进行了大量的研究来鉴定新型的HbF诱导剂并了解刺激HbF产生的潜在机制。在这篇综述中,我们总结了目前已鉴定出的HbF诱导剂。通过研究HbF诱导剂的作用机理,各种研究表明,尽管具有刺激HbF产生的能力,但由于其细胞毒性和抗氧化剂,该化学治疗剂仍不能实际用于治疗β-血红蛋白病,特别是β-地中海贫血。抑制生长的作用。由于这种治疗上的障碍,人们花了很多精力从自然界中鉴定出新的HbF诱导剂,并结合了功效,安全性和易用性。因此,本综述旨在(i)揭示新颖的筛选平台,以高效,准确地鉴定潜在的诱导物,以及(ii)总结新鉴定的刺激HbF产生的自然疗法。希望这篇综述可以为治疗β地中海贫血和SCD的胎儿血红蛋白活化的现状和未来观点提供新的见解。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号